|
|
|
By Dan Schell, chief editor, Clinical Leader | If you want to know about how perceptions regarding DCTs are changing, talk with Jane Myles, Program Director of the Decentralized Trials & Research Alliance (DTRA). She is acutely aware of all the challenges and opportunities surrounding anything with the term “decentralized trial.” |
|
|
|
| eConsent For Complex Clinical Trials | Article | By Karen Maduschke and Vinita Navadgi, IQVIA Technologies | Master protocol design trials require an endless stream of consent forms, adding time, cost, and risk. Learn how a feature-rich eConsent platform can simplify those processes and improve engagement. |
|
|
|
|
|
|
| Enhancing Clinical Trials By Linking Them To RWD | Poster | Medidata AI | Discover the strategic advantage of integrating participant trial data and real-world data into your EDC system, streamlining the IRB approval process for enhanced study success. |
|
|
| Key Insights From The FDA's DHT Guidance | Article | By Cindy Howry, Medable | Check out a summary of the FDA’s guidance Framework for the Use of DHTs in Clinical Trials and what it means for sponsors and investigators using these innovative tools. |
|
|
| 7 Insights From A Clinical Trial Operations Technology Survey | Article | By Blake Adams, Florence Healthcare | To stay competitive in the clinical research field, sites, sponsors, and CROs need to invest in remote technology. Unearth seven trends that your clinical trial team needs to know about to maintain success. |
|
|
.png){kind=logo}
